Clinical Trials in Boston

Showing 2761-2780 of 17,836 trials

Veterans Coordinated Community Care (3C) Study

NCT05272176

Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related behaviors (including deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts) and suicidal ideation and functioning.

Suicide

Brown University850 participantsStarted Jan 2022

Little Rock, Arkansas, United States • Boston, Massachusetts, United States • Minneapolis, Minnesota, United States +4 more locations

COMPLETEDPhase 2< 1 mile

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

NCT05431387

This placebo-controlled Phase 2 study is being conducted at sites within the United States to evaluate the efficacy and safety profile of 3 mg cytisinicline administered TID for 12 weeks for vaping cessation.

VapingE-Cig Use

Achieve Life Sciences160 participantsStarted Jul 2022

Lexington, Kentucky, United States • Boston, Massachusetts, United States • Rochester, New York, United States +2 more locations

Veterans Coordinated Community Care (3C) Study

A Study of Cytisinicline for Vaping Cessation in Adult Smokers

Find Trials by Condition in Boston

Diffuse Cutaneous Scleroderma (DSSc) SFDI Study

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

Cerliponase Alfa Observational Study in the US

Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma

Decision Making, Daily Experiences, and Brain Activity in Young Adult Women

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Artificial Urinary Sphincter Clinical Outcomes

A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Responses to E-cigarette Message Source and Presentation

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Phase III Trial of Sirolimus in IBM